Salarius Pharmaceuticals Inc. buy melinda
Start price
15.04.17
/
50%
€49,892
Target price
27.04.17
€57,784
Performance (%)
9.04%
End price
27.04.17
€54,402
Summary
This prediction ended on 27.04.17 with a price of €54,402. The BUY prediction by melinda finished with a performance of 9.04%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Salarius Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 0.608% | 0.340% | 12.057% | 58.100% |
| iShares Nasdaq 100 | 0.636% | -3.172% | 1.743% | 84.363% |
| iShares Nikkei 225® | -0.128% | 8.916% | 27.388% | 64.836% |
| iShares S&P 500 | 0.544% | -0.699% | 1.915% | 58.669% |
Comments by melinda for this prediction
In the thread Flex Pharma Inc. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
hat $
(Vom Mitglied beendet)
Stopped prediction by melinda for Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€51,442
12.06.17
12.06.17
€57,784
21.06.17
21.06.17
14.25%
21.06.17
21.06.17


